Lifeboat Foundation

Bipolar disorder (BD) is a debilitating condition characterized by alternating states of depression (known as depressive episodes) and abnormal excitement or irritability (known as manic episodes). Large-scale genome-wide association studies (GWASs) have revealed that variations in the genes present on the fatty acid desaturase (FADS) locus are linked to an increased risk of BD.

Enzymes coded by FADS genes—FADS1 and FADS2—convert or “biosynthesize” omega-3 fatty acids into the different forms required by the human body. Omega-3 fatty acids like eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are crucial for the brain to function, and a reduction in the synthesizing activity of these molecules seems to increase susceptibility to bipolar mood swings.

Research on most diseases involves establishment of an animal model of the disease. So, keeping this knowledge in mind, a team of researchers including Dr. Takaoki Kasahara and Hirona Yamamoto from RIKEN Brain Science Institute and Dr. Tadafumi Kato from Juntendo University in Japan, used CRISPR-Cas9 gene editing to create mutant mice that lack both Fads1 and Fads2 genes.

Scientists working in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute at Trinity College Dublin have made an important breakthrough in understanding what goes wrong in our bodies during the progression of inflammatory diseases and—in doing so—unearthed a potential new therapeutic target.

The scientists have found that an enzyme called fumarate hydratase is repressed in macrophages, a frontline inflammatory cell type implicated in a range of diseases including lupus, arthritis, sepsis and COVID-19.

Professor Luke O’Neill, Professor of Biochemistry at Trinity, is the lead author of the research article that has just been published in the journal, Nature. He said, “No one has made a link from fumarate hydratase to inflammatory macrophages before and we feel that this process might be targetable to treat debilitating diseases like lupus, which is a nasty autoimmune disease that damages several parts of the body including the skin, kidneys and joints.”

Summary: As the brain ages, microglia adopt dysfunctional states that increase the risk of developing neurodegenerative diseases such as Alzheimer’s disease.

Source: TCD

Scientists from the Trinity Biomedical Sciences Institute (TBSI) have shed new light on aging processes in the brain. By linking the increased presence of specialised immune cells to conditions such as Alzheimer’s disease and traumatic brain injury for the first time, they have unearthed a possible new target for therapies aimed at treating age-related neurological diseases.

Nearly 270,000 people in the United States are diagnosed with breast cancer each year.

According to the Susan G. Komen Foundation, about 70%–80% of these individuals experience estrogen receptor-positive (ER+) breast cancer, where cancer cells need estrogen to grow. In terms of treatment, this presence of hormone receptors provides a nice handle for targeting tumors, say with therapies that knock out the tumor cell’s ability to bind to estrogen and prevent remaining breast cancer cells from growing.

However, even if treated successfully, on average, one in five individuals with ER+ breast cancer experience a late recurrence when dormant tumor cells in distant parts of the body, such as the bone marrow, reactivate anywhere from five to over 20 years after initial treatment.

Making living cells blink fluorescently like party lights may sound frivolous. But the demonstration that it’s possible could be a step toward someday programming our body’s immune cells to attack cancers more effectively and safely.

That’s the promise of the field called synthetic biology. While molecular biologists strip cells down to their component genes and molecules to see how they work, synthetic biologists tinker with cells to get them to perform new feats — discovering new secrets about how life works in the process. In this episode, Steven Strogatz talks with Michael Elowitz, a professor of biology and bioengineering at the California Institute of Technology and a Howard Hughes Medical Institute Investigator.

The health of the heart and blood vessels is vital to body function. Early screening can help people understand their risks and potentially prevent adverse health outcomes.

Testing cholesterol levels is important, but another test can further help identify the risk for cardiovascular disease: apolipoprotein B-100 (ApoB) levels. This protein helps transport cholesterol throughout the body.

Testing for the level of this protein in the blood may help identify people who are more at risk for cardiovascular disease, even when cholesterol levels are normal.

A new study has taken ‘biotechnology’ to a whole new level. Researchers have developed a gel that facilitates electrode growth in zebrafish and medicinal leech tissues.

Researchers from Linköping, Lund and Gothenburg universities (all Sweden) have developed a gel that becomes electrically conductive when injected into tissue, relying on molecules found in the body to trigger conductivity. This could lead to the development of further human–machine integrations that can help us understand complex biological functions and fight disease.

Previously, combining bioelectronics with living organisms’ signaling systems has been difficult and often relied on external signals, such as light or electrical energy. The current study’s bioelectronic gel bypasses these issues by being flexible and soft enough to interact with tissues while remaining sturdy enough to be injectable; additionally, the gel requires no external signals to become electrically conductive. Instead, the body’s endogenous molecular signals are enough for activation.

Iwas never into house plants until I bought one on a whim—a prayer plant, it was called, a lush, leafy thing with painterly green spots and ribs of bright red veins. The night I brought it home I heard a rustling in my room. Had something scurried? A mouse? Three jumpy nights passed before I realized what was happening: The plant was moving. During the day, its leaves would splay flat, sunbathing, but at night they’d clamber over one another to stand at attention, their stems steadily rising as the leaves turned vertical, like hands in prayer.

“Who knew plants do stuff?” I marveled. Suddenly plants seemed more interesting. When the pandemic hit, I brought more of them home, just to add some life to the place, and then there were more, and more still, until the ratio of plants to household surfaces bordered on deranged. Bushwhacking through my apartment, I worried whether the plants were getting enough water, or too much water, or the right kind of light—or, in the case of a giant carnivorous pitcher plant hanging from the ceiling, whether I was leaving enough fish food in its traps. But what never occurred to me, not even once, was to wonder what the plants were thinking.

To understand how human minds work, he started with plants.

X-ray diffraction has been used for more than a hundred years to understand the structure of crystals or proteins—for instance, in 1952 the well-known double helix structure of the DNA that carries genetic information was discovered in this way. In this technique, the object under investigation is bombarded with short-wavelength X-ray beams. The diffracted beams then interfere and thus create characteristic diffraction patterns from which one can gain information about the shape of the object.

For several years now it has been possible to study even single nanoparticles in this way, using very short and extremely intense X-ray pulses. However, this typically only yields a two-dimensional image of the particle. A team of researchers led by ETH professor Daniela Rupp, together with colleagues at the universities of Rostock and Freiburg, the TU Berlin and DESY in Hamburg, have now found a way to also calculate the three-dimensional structure from a single diffraction pattern, so that one can “look” at the particle from all directions. In the future it should even be possible to make 3D-movies of the dynamics of nanostructures in this way. The results of this research have recently been published in the scientific journal Science Advances.

Daniela Rupp has been assistant professor at ETH Zurich since 2019, where she leads the research group “Nanostructures and ultra-fast X-ray science.” Together with her team she tries to better understand the interaction between very intense X-ray pulses and matter. As a model system they use nanoparticles, which they also investigate at the Paul Scherrer Institute. “For the future there are great opportunities at the new Maloja instrument, on which we were the first user group to make measurements at the beginning of last year. Right now our team there is activating the attosecond mode, with which we can even observe the dynamics of electrons,” says Rupp.